Discontinued — last reported Q3 '25
Nordson Medical and Fluid Solutions — Operating profit (loss) decreased by 7.6% to $52.50M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.5%, from $48.37M to $52.50M. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates improved pricing power, better cost management, or higher sales volume within the medical and fluid product lines. A decrease may signal rising input costs, pricing pressure, or operational inefficiencies in this specific segment.
This metric represents the operating income generated by the Medical and Fluid Solutions segment, calculated as segment...
Comparable to segment-level operating income reported by diversified industrial or medical device manufacturers with specialized fluid management divisions.
ndsn_segment_medical_and_fluid_solutions_operating_profit_loss| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $49.09M | $58.31M | $58.10M | $39.38M | $47.92M | $54.02M | $46.10M | $48.99M | $48.37M | $40.94M | $56.81M | $52.50M |
| QoQ Change | — | +18.8% | -0.4% | -32.2% | +21.7% | +12.7% | -14.7% | +6.3% | -1.3% | -15.4% | +38.8% | -7.6% |
| YoY Change | — | — | — | -19.8% | -17.8% | -7.0% | +17.1% | +2.2% | -10.5% | -11.2% | +15.9% | +8.5% |